Weleader Biomedical CoROCO:7713 47 Days Payable is 99.23 as of Dec. 2025, which is 19% above its 10-year median of 83.70. GuruFocus rates ROCO:7713 with a GF Score™ of 47/100. The stock has 5 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Weleader Biomedical Co ranks better than 65.45% on this metric.
The historical rank and industry rank for Weleader Biomedical Co's Days Payable or its related term are showing as below:
ROCO:7713'
s Days Payable Range Over the Past 10 Years
Min: 76.78 Med: 83.7 Max: 101.24
Current: 101.24
During the past 6 years, Weleader Biomedical Co's highest Days Payable was 101.24. The lowest was 76.78. And the median was 83.70.
ROCO:7713's Days Payable is ranked better than 65.45% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs ROCO:7713: 101.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7713 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Weleader Biomedical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Weleader Biomedical Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Weleader Biomedical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Weleader Biomedical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Weleader Biomedical Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Weleader Biomedical Co (ROCO:7713) has a Days Payable of 99.23 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Weleader Biomedical Co and its competitors. This is 19% above median its historical median of 83.70. Over the past decade, Weleader Biomedical Co's Days Payable has ranged from 76.78 to 101.24. According to the industry distribution chart, Weleader Biomedical Co ranks #275 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 34.5%.
Is Weleader Biomedical Co's Days Payable too high?
Weleader Biomedical Co's current Days Payable of 99.23 is 19% above median its 10-year median of 83.70. Over the past 10 years, this metric has ranged from a low of 76.78 to a high of 101.24. The Medical Devices & Instruments industry median Days Payable is 67.97. Weleader Biomedical Co's value of 99.23 is 46% above this industry median. Based on the distribution chart, Weleader Biomedical Co ranks #275 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Weleader Biomedical Co has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Weleader Biomedical Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Weleader Biomedical Co ranks #275 out of 796 companies for Days Payable. This puts Weleader Biomedical Co in the upper half of its industry. The industry median Days Payable is 67.97. Weleader Biomedical Co's value of 99.23 is 46% above this benchmark. Historically, Weleader Biomedical Co's own Days Payable has ranged from 76.78 to 101.24 over the past decade. While the company's 10-year median is 83.70 vs. the industry median of 67.97, Weleader Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Weleader Biomedical Co's current Days Payable of 99.23 is 46% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Weleader Biomedical Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Weleader Biomedical Co's current Days Payable is 99.23, which is 19% above median its own 10-year median of 83.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Weleader Biomedical Co stock overvalued right now?
Weleader Biomedical Co (ROCO:7713) has a current Days Payable of 99.23. The current Days Payable is 99.23, which is 19% above median its 10-year median of 83.70 and 46% above the Medical Devices & Instruments industry median of 67.97. Weleader Biomedical Co's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Weleader Biomedical Co (ROCO:7713), the current Days Payable is 99.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Weleader Biomedical Co Ltd is mainly engages in the sales of medical testing reagents and medical devices; and the leasing of testing instruments. The reportable segments of the Group are: The Company, which includes sale of testing reagents, and provision of testing instruments and services; and Health Leader, which includes sale of dietary supplements and testing reagents, and provision of information and professional services. It derives majority revenue from the Company segment. Geographically, the company operates and generates revenue from Taiwan.
47GF Score
Get the complete analysis for ROCO:7713
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7713 has been successfully added to your 
